Nebraska Medicine Fred and Pamela Buffett Cancer Center — Omaha, Nebraska

Nebraska Medicine Fred and Pamela Buffett Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68105.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Medicine Fred and Pamela Buffett Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Sponsors: Juno Therapeutics, a Subsidiary of Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

• Methodist Cancer Center at Methodist Hospital - Omaha
• Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha
• University of Nebraska Medical Center, College of Nursing
• Nebraska Medical Hospital
• University of Nebraska Medical Center, Lauritzen Outpatient Center
• Creighton University Psychiatry Research Center
• VA Medical Center, Omaha
• Marc Rendell, MD - Creighton University
• The Cardiac Center of Creighton University
• Methodist Hospital Cancer Center - Omaha
• University of Nebraska /ID# 203195
• Eppley Cancer Center, University of Nebraska Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Medicine Fred and Pamela Buffett Cancer Center?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Medicine Fred and Pamela Buffett Cancer Center conducted?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has 1 clinical trials on record. Their work covers Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Is Nebraska Medicine Fred and Pamela Buffett Cancer Center accredited by Crixeo Clinical Trials?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Medicine Fred and Pamela Buffett Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.